Recently, Hedwig Braakhuis from Maastricht University and other Dutch colleagues have published a comprehensive review about in vitro systems to study translocation of nanoparticles through barriers (Braakhuis et al. 2015) . Numerous in vivo studies have shown that nanoparticles can cross the barrier of the lung, gut, skin and placenta (Balasubramanian et al. 2010; Braakhuis et al. 2015; Creutzenberg et al. 2012; Elder et al. 2006; Semmler et al. 2004 ) and translocate directly via axons of the olfactory nerve into the CNS (Oberdorster et al. 2004) . The degree to which these barriers can be passed depends on the physicochemical properties of the particles and varies widely between different particle types. Therefore, it would represent a large progress if this capacity could be predicted in vitro. In their comprehensive review, Braakhuis and colleagues critically discuss the large number of in vitro systems of barriers particularly of lung, gut, skin and placenta. The authors conclude that although these systems allow identification of qualitative differences between particles they have not yet been sufficiently calibrated with respect to the in vivo situation. The currently available in vitro systems of barriers do not yet allow quantitative predictions of real organisms (Braakhuis et al. 2015) .
Currently, nanotoxicology represents one of the most intensively studied fields of toxicology (Hammad et al. 2014; Marchan 2012; Stewart and Marchan 2012 
